GlassScriptPhysician profile
Rahul Gilotra
NPI 1730299298
$460.37
in general payments reported to CMS, 2019-2025
8 companies · $41.64 in 2025
The $41.64 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23.81 · 2022: $269 · 2023: $84.78 · 2024: $41.15 · 2025: $41.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $168.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $167.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $155.96 | 2022-2023 | Zeposia |
| Philips North America LLC | $113.41 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $80.72 | 2022-2025 | Entyvio |
| Abbvie INC. | $38.10 | 2022-2023 | |
| Shionogi INC | $23.81 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $18.02 | 2025 | Dupixent |
| Redhill Biopharma INC. | $16.58 | 2023 | Talicia |
| Mauna Kea Technologies, INC. | $13.77 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rahul Gilotra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.